• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KANEKA CORPORETION LIXELLE BETA2-MICROGLOBULIN APHERESIS COLUMN; BETA 2-MICROGLOBULIN APHERESIS COLUMN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KANEKA CORPORETION LIXELLE BETA2-MICROGLOBULIN APHERESIS COLUMN; BETA 2-MICROGLOBULIN APHERESIS COLUMN Back to Search Results
Model Number S-15
Device Problems Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
Patient Problem Low Blood Pressure/ Hypotension (1914)
Event Date 09/14/2022
Event Type  Injury  
Event Description
About 1 hour and 30 minutes after the start of treatment, the systolic blood pressure dropped to the 50 mmhg level after the development of yawning.We performed leg elevation, electrolyte replenishment, and discontinuation of dialysis (ultrafiltration), but the blood pressure did not improve, so extracorporeal circulation treatment was discontinued.
 
Manufacturer Narrative
Our view: there were no reports of product defects, etc.From the facility, and we determined that the cause of the adverse events was the patient's condition and method of use.When the blood pressure dropped, no symptoms such as nausea or a decline in the level of consciousness were observed in the patient, but it was surmised that systolic blood pressure of the 50 mmhg level "may cause serious damage to peripheral tissues".The case was judged to be a "serious" case.In addition, since a causal relationship between the adverse event and the product cannot be completely denied, it was determined that the mdr 30-day report applies.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIXELLE BETA2-MICROGLOBULIN APHERESIS COLUMN
Type of Device
BETA 2-MICROGLOBULIN APHERESIS COLUMN
Manufacturer (Section D)
KANEKA CORPORETION
nakanoshima
kita-ku 2-3-18
osaka, osaka 530-8 5288
JA  530-85288
Manufacturer (Section G)
KANEKA CORPORATION OSAKA PLANT
5-1-1
torikai-nishi
settu-shi, osaka 566-0 072
JA   566-0072
Manufacturer Contact
joji sengoku
1-12-32
akasaka minato-ku
tokyo 107-6-028
JA   107-6028
MDR Report Key15602427
MDR Text Key301728378
Report Number3002808904-2022-00013
Device Sequence Number1
Product Code PDI
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberS-15
Device Catalogue NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/16/2022
Initial Date FDA Received10/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age70 YR
Patient SexMale
Patient Weight57 KG
Patient EthnicityNon Hispanic
Patient RaceAsian
-
-